Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-pack… Read more
Market Cap & Net Worth: Repligen Corporation (RGEN)
Repligen Corporation (NASDAQ:RGEN) has a market capitalization of $6.48 Billion ($6.48 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2417 globally and #1707 in its home market, demonstrating a -4.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Repligen Corporation's stock price $115.11 by its total outstanding shares 56290749 (56.29 Million).
Repligen Corporation Market Cap History: 2015 to 2026
Repligen Corporation's market capitalization history from 2015 to 2026. Data shows growth from $1.59 Billion to $6.48 Billion (13.55% CAGR).
Index Memberships
Repligen Corporation is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Biotechnology
BTK
|
$880.78 Billion | 0.69% | #20 of 30 |
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.27% | #54 of 976 |
|
NASDAQ Composite
IXIC
|
$33.26 Trillion | 0.02% | #305 of 3165 |
|
S&P Midcap 400
MID
|
$3.04 Trillion | 0.24% | #201 of 401 |
Weight: Repligen Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Repligen Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Repligen Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
12.77x
Repligen Corporation's market cap is 12.77 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.59 Billion | $83.54 Million | $9.35 Million | 19.06x | 170.41x |
| 2016 | $1.73 Billion | $104.54 Million | $11.68 Million | 16.60x | 148.52x |
| 2017 | $2.04 Billion | $141.24 Million | $28.35 Million | 14.46x | 72.03x |
| 2018 | $2.97 Billion | $194.03 Million | $16.62 Million | 15.30x | 178.66x |
| 2019 | $5.21 Billion | $270.25 Million | $21.41 Million | 19.27x | 243.19x |
| 2020 | $10.79 Billion | $366.26 Million | $59.93 Million | 29.45x | 180.01x |
| 2021 | $14.91 Billion | $670.53 Million | $128.29 Million | 22.23x | 116.20x |
| 2022 | $9.53 Billion | $801.54 Million | $185.96 Million | 11.89x | 51.25x |
| 2023 | $10.12 Billion | $638.76 Million | $41.58 Million | 15.84x | 243.43x |
| 2024 | $8.10 Billion | $634.44 Million | -$25.51 Million | 12.77x | N/A |
Competitor Companies of RGEN by Market Capitalization
Companies near Repligen Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Repligen Corporation by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #99 globally with a market cap of $170.64 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #355 globally with a market cap of $61.46 Billion USD ( €59.87 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.52 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #99 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.64 Billion | $483.46 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #355 | EssilorLuxottica S. A. | PA:EL | $61.46 Billion | €203.90 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.52 Billion | $160.27 |
Repligen Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Repligen Corporation's market cap moved from $1.59 Billion to $ 6.48 Billion, with a yearly change of 13.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.48 Billion | -29.75% |
| 2025 | $9.22 Billion | +13.84% |
| 2024 | $8.10 Billion | -19.94% |
| 2023 | $10.12 Billion | +6.20% |
| 2022 | $9.53 Billion | -36.07% |
| 2021 | $14.91 Billion | +38.20% |
| 2020 | $10.79 Billion | +107.17% |
| 2019 | $5.21 Billion | +75.39% |
| 2018 | $2.97 Billion | +45.37% |
| 2017 | $2.04 Billion | +17.72% |
| 2016 | $1.73 Billion | +8.94% |
| 2015 | $1.59 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Repligen Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.48 Billion USD |
| MoneyControl | $6.48 Billion USD |
| MarketWatch | $6.48 Billion USD |
| marketcap.company | $6.48 Billion USD |
| Reuters | $6.48 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.